These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12401270)

  • 1. The future of dengue vaccines.
    Halstead SB; Deen J
    Lancet; 2002 Oct; 360(9341):1243-5. PubMed ID: 12401270
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: the challenge of dengue vaccine development and introduction.
    Deen JL
    Trop Med Int Health; 2004 Jan; 9(1):1-3. PubMed ID: 14728601
    [No Abstract]   [Full Text] [Related]  

  • 3. Dengue vaccine design: issues and challenges.
    Cardosa MJ
    Br Med Bull; 1998; 54(2):395-405. PubMed ID: 9830205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe dengue: the need for new case definitions.
    Rigau-Pérez JG
    Lancet Infect Dis; 2006 May; 6(5):297-302. PubMed ID: 16631550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of dengue vaccines and prospects for the future.
    Bancroft WH
    P R Health Sci J; 1987 Apr; 6(1):23-6. PubMed ID: 3615797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dengue, a growing problem of health in the Americas].
    Kourí G
    Rev Panam Salud Publica; 2006 Mar; 19(3):143-5. PubMed ID: 16640842
    [No Abstract]   [Full Text] [Related]  

  • 7. Dengue virus vaccine studies in Puerto Rico: a review.
    Kraiselburd E
    P R Health Sci J; 1987 Apr; 6(1):27-9. PubMed ID: 3615798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dengue and dengue hemorrhagic fever: research priorities].
    Guzmán MG; García G; Kourí G
    Rev Panam Salud Publica; 2006 Mar; 19(3):204-15. PubMed ID: 16640849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of dengue virus and the development of a vaccine.
    Murrell S; Wu SC; Butler M
    Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses.
    Brandt WE
    J Infect Dis; 1988 May; 157(5):1105-11. PubMed ID: 2452218
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.
    Kitchener S; Nissen M; Nasveld P; Forrat R; Yoksan S; Lang J; Saluzzo JF
    Vaccine; 2006 Feb; 24(9):1238-41. PubMed ID: 16213632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovirulence effects of dengue-2 viruses on the rhesus (Macaca mulatta) brain and spinal cord.
    Angsubhakorn S; Moe JB; Marchette NJ; Palumbo NE; Yoksan S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):52-5. PubMed ID: 3660068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue vaccines: preparing to roll back dengue.
    Jacobs M; Young P
    Curr Opin Investig Drugs; 2003 Feb; 4(2):168-71. PubMed ID: 12669377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
    BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.
    Chambers TJ; Tsai TF; Pervikov Y; Monath TP
    Vaccine; 1997 Oct; 15(14):1494-502. PubMed ID: 9330458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Future prospects in developing of dengue vaccines].
    Valero N; Levy A
    Invest Clin; 2008 Jun; 49(2):135-8. PubMed ID: 18717261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
    Robert Putnak J; Coller BA; Voss G; Vaughn DW; Clements D; Peters I; Bignami G; Houng HS; Chen RC; Barvir DA; Seriwatana J; Cayphas S; Garçon N; Gheysen D; Kanesa-Thasan N; McDonell M; Humphreys T; Eckels KH; Prieels JP; Innis BL
    Vaccine; 2005 Aug; 23(35):4442-52. PubMed ID: 16005749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deadly dengue: new vaccines promise to tackle this escalating global menace.
    Shekhar C
    Chem Biol; 2007 Aug; 14(8):871-2. PubMed ID: 17719483
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine prospects for dengue haemorrhagic fever.
    World Health Forum; 1993; 14(2):203. PubMed ID: 8185774
    [No Abstract]   [Full Text] [Related]  

  • 20. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.
    Raviprakash K; Apt D; Brinkman A; Skinner C; Yang S; Dawes G; Ewing D; Wu SJ; Bass S; Punnonen J; Porter K
    Virology; 2006 Sep; 353(1):166-73. PubMed ID: 16814355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.